BRII-753

N/A

Report date: 2025/12/16 17:18:10
NME

Base Information

Drug NameBRII-753
Drug Alias NameBRII-753
ClassificationSmall molecules > Prodrug
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsNucleoside reverse transcriptase translocation inhibitor
TargetsNucleotide reverse transcriptaseHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrii Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrii Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A